Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...

The average age of men who get diagnosed is 67.

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every eight American men will be diagnosed with prostate cancer at some point, an ...

Prostate Cancer Survivor, Jerry McCormick, urges Black men 45 years and older to get screened as soon as possible, because early detection could save their life.

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...